MedTrace Logo

Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation

NCT02718703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2016-09-14

No results posted yet for this study

Summary

Clinical Evaluation including System Accuracy, User Performance and System Use Evaluation of a new Blood Glucose Monitoring System.

Conditions

Interventions

DEVICE

Blood Glucose Monitoring System.

In vitro diagnostic medical device

Sponsors & Collaborators

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • Lorna Stewart · LifeScan

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718703 on ClinicalTrials.gov